<DOC>
	<DOC>NCT00701181</DOC>
	<brief_summary>To evaluate the effectiveness of study drug in improving visual acuity compared to laser treatment in the patients with diabetic macular edema</brief_summary>
	<brief_title>Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema</brief_title>
	<detailed_description>DEGAS termination decision date was December 17, 2010. Rationale: the objectives of the study could no longer be achieved. The study was not terminated for safety.</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<criteria>Patients with Diabetes Mellitus (Type 1 or Type 2) Showing Diabetic Macular Edema in the Eye. Proliferative Diabetic Retinopathy in the Study Eye. Subjects Receiving Concomitant Intravitreal AntiVEGF Therapy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Phase II</keyword>
	<keyword>Prospective</keyword>
	<keyword>Randomized</keyword>
	<keyword>Diabetic Macular Edema</keyword>
	<keyword>PF-04523655</keyword>
	<keyword>Laser</keyword>
</DOC>